XRTX
XORTX Therapeutics Inc
NASDAQ: XRTX · HEALTHCARE · BIOTECHNOLOGY
$2.86
+4.76% today
Updated 2026-04-30
Market cap
$4.22M
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-2.80
Dividend yield
—
52W range
$2 – $7
Volume
1.5M
XORTX Therapeutics Inc (XRTX) Financial statements
SEC filings — annual and quarterly data.
Cash flow — annual
| Item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $-85362.00 | $-128574.00 | $-107784.00 | $72504.00 | $-1.56M | $-249580.00 | $-728401.00 | $-4.80M | $-8.96M | $-6.58M | $-5.04M | $-3.87M |
| Capital expenditures | $24113.00 | $39111.00 | $3790.00 | $9927.00 | $30155.00 | $5387.00 | $11253.00 | $31807.00 | $45701.00 | $46363.00 | $3.00 | $4.00 |
| Depreciation | — | — | — | — | — | — | — | — | — | — | — | — |
| Stock-based comp | — | $35653.00 | $218.00 | $92672.00 | $275094.00 | $26317.00 | $293443.00 | $576012.00 | $487940.00 | $120984.00 | $122527.00 | $25155.00 |
| Free cash flow | $-109475.00 | $-167685.00 | $-111574.00 | $62577.00 | $-1.59M | $-254967.00 | $-739654.00 | $-4.83M | $-9.01M | $-6.63M | $-5.04M | $-3.87M |
| Investing cash flow | — | — | — | — | — | — | — | — | — | — | — | — |
| Financing cash flow | — | — | — | — | — | — | — | — | — | — | — | — |
| Dividends paid | — | — | — | — | — | — | — | — | — | — | — | — |
| Share repurchases | — | — | — | — | — | — | — | — | — | — | — | — |
| Debt repayment | — | — | — | — | — | — | — | — | — | — | — | — |
| Net change in cash | — | — | — | — | — | — | — | — | — | — | — | — |